Two Sigma Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-70,163
| Closed | -$22.9K | – | 3266 |
|
|
2023
Q2 | $22.9K | Sell |
70,163
-7
| -0% | -$2 | ﹤0.01% | 2815 |
|
|
2023
Q1 | $30.2K | Sell |
70,170
-900
| -1% | -$387 | ﹤0.01% | 2741 |
|
|
2022
Q4 | $37.7K | Sell |
71,070
-51,592
| -42% | -$27.3K | ﹤0.01% | 2561 |
|
|
2022
Q3 | $90K | Buy |
+122,662
| New | +$90K | ﹤0.01% | 2195 |
|
|
2022
Q2 | – | Sell |
-107,747
| Closed | -$221K | – | 3018 |
|
|
2022
Q1 | $221K | Buy |
107,747
+81,651
| +313% | +$167K | ﹤0.01% | 2275 |
|
|
2021
Q4 | $75K | Sell |
26,096
-164,334
| -86% | -$472K | ﹤0.01% | 2437 |
|
|
2021
Q3 | $807K | Buy |
190,430
+124,954
| +191% | +$530K | ﹤0.01% | 1796 |
|
|
2021
Q2 | $346K | Buy |
65,476
+1,730
| +3% | +$9.14K | ﹤0.01% | 2082 |
|
|
2021
Q1 | $296K | Buy |
+63,746
| New | +$296K | ﹤0.01% | 2047 |
|
|
2020
Q1 | – | Sell |
-69,563
| Closed | -$420K | – | 2528 |
|
|
2019
Q4 | $420K | Buy |
+69,563
| New | +$420K | ﹤0.01% | 1752 |
|
|
2019
Q1 | – | Sell |
-40,447
| Closed | -$120K | – | 2524 |
|
|
2018
Q4 | $120K | Buy |
+40,447
| New | +$120K | ﹤0.01% | 1932 |
|
|
2016
Q2 | – | Sell |
-14,851
| Closed | -$140K | – | 2401 |
|
|
2016
Q1 | $140K | Buy |
+14,851
| New | +$140K | ﹤0.01% | 1964 |
|